For the year ending 2025-12-31.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Research and development | 184,698 | |||
| General and administrative | 31,709 | |||
| Total operating expenses | 216,407 | |||
| Loss from operations | -216,407 | |||
| Interest and other income, net | 9,717 | |||
| Net loss | -206,690 | |||
| Deemed dividend on modification of common stock warrants | 1,857 | |||
| Net loss attributable to common stockholders | -208,547 | |||
| Basic EPS | -1.34 | |||
| Diluted EPS | -1.34 | |||
| Basic Average Shares | 155,105,832 | |||
| Diluted Average Shares | 155,105,832 | |||
Annexon, Inc. (ANNX)
Annexon, Inc. (ANNX)